Health Services Research
Latest posts by Health Services Research (see all)
- Emergency Department Attendance after Telephone Triage: A Population-Based Data Linkage Study - Mar. 30, 2017
- Medicare’s Acute Care Episode Demonstration: Effects of Bundled Payments on Costs and Quality… - Mar. 29, 2017
- Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees - Mar. 27, 2017
- Physician Competition in the Era of Accountable Care Organizations - Mar. 27, 2017
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: